2 Potential Biotech Doublers
Today’s article features two biotech stocks that analysts believe have the potential to double over the next 12 months. The first company is developing therapies… Read More »2 Potential Biotech Doublers
Today’s article features two biotech stocks that analysts believe have the potential to double over the next 12 months. The first company is developing therapies… Read More »2 Potential Biotech Doublers
The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
When it comes to the best way to gauge biotech stocks ahead of big catalysts, the author of today’s article recommends turning to Wall Street… Read More »Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
As a manufacturer of COVID-19 tests – and the top provider of COVID-19 testing in California – the company featured in today’s article has seen… Read More »Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
Unless you’re a full-time trader who’s able to spend all day researching and developing stock screens, it’s not easy to find compelling biotech stocks, right?… Read More »An Easy Way For Anyone To Find Compelling Biotech Stocks
The underperforming biotech featured in today’s article may be well positioned to become an outperformer. How? As the author explains, the company “may soon be… Read More »Expanding Its “Crown Jewel” Medication Into Dermatology Could Take This Biotech From Underperformer To Outperformer
After ending the month of February on a weak note, what does the first week of March have in store for biotech stocks? Today’s article… Read More »After Last Week’s Weakness, What Does This Week Have In Store For Biotech Stocks?
Regardless of whether the COVID-19 pandemic abates this year or not, the telehealth trend is expected to continue – and that could help one of… Read More »A Return To Normal Or More ‘New Normal’, 2 Healthcare Stocks That Could Soar This Year
Today’s article highlights two clinical-stage biotech stocks that analysts believe are not only likely to be winners this year, but that have the potential to… Read More »These 2 Biotech Stocks Could Double – Or More – This Year
Life sciences companies, biopharmaceutical companies and more make up the 11 new biotech stocks to watch highlighted in today’s article, which also highlights several new… Read More »New Biotech And Tech Stocks To Watch